Journals / Endokrinolojide Yönelişler / 2004 / Cilt: 13 - Sayı: 2

Nörolojik semptom skorlama sistemlerinin diyabetik polinöropati tanısındaki önemi

Importance of the neurologic symptom score systems in diagnosis of diabetic polyneuropathy

Pages
64–67
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

NDS and NSS were found to be closely correlated with EMNG result (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neuropathy is a common complication among the patients with diabetes mellitus.
📊
Key Findings & Data:In this study, the ability of these scoring systems were compared to EMNG and reliability of these diagnostic tools were assessed.One hundred diabetic patients (67-type 2 and 33 type 1) were included in the study.
💡
Conclusion & Impact:NDS and NSS were found to be closely correlated with EMNG result (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Neuropathy is a common complication among the patients with diabetes mellitus. Electromyoneurography (EMNG) done by an experienced neurologist is sensiti¬ve in detecting diabetic polyneuropathy. In some neurology clinics, Neuropathy Symptom Score (NSS) and Neuropathy Disability Score (NDS) systems can also be used for the diagnosis of diabetic polyneuropathy. In this study, the ability of these scoring systems were compared to EMNG and reliability of these diagnostic tools were assessed.One hundred diabetic patients (67-type 2 and 33 type 1) were included in the study. EMNG examination was performed on median, peroneal and sural nerves of three extremities as both legs and one arm. All of the subjects answered the questions in NSS and neurologic examination was performed for each patient that results were scored according to NDS. Polyneuropathy was present in 69 % of diabetics. Sixty one patients had mixed sensorymotor polyneuropathy, 4 had sensory and 4 had motor polyneuropathy. NDS and NSS were found to be closely correlated with EMNG result (p

Özet

Diyabetik nöropati diyabetli hastaların çoğunluğunda karşılaşılan ciddi bir komplikasyondur. Diyabetik nöropatinin tanısında uzmanlarca elekromyografi (EMGP) kullanıldı. Bazı nöroloji kliniklerinde Nöropati Semptom Skor (NSS) ve Nöropati yetersizlik Skor (NDS) sistemleri diyabetik nöropati tanısında kullanılmaktadır. Bu çalışmada EMNG ve skorlama sistemlerinin birbirlerine olan üstünlükleri ve yararlılıkları karşılaştırılmıştır. Bu çalışmaya 100 diyabetik hasta katılmıştır (67 si Tip 2 DMö 33 ü tip 1 DM hastası). EMNG çalışması 3 ekstremite de median, perineal ve sural sinir incelemeleriyle yapılmıştır. Çalışmaya katılan tüm hastalar skorlama sisteminin değerlendirilmesi için hazırlanan nörolojik soruları yanıtlamış ve nörolojik muayeneden geçmiştir. Çalışma grubunda 69 diyabetik hastada polinöropati tanısı konmuştur. Bunlardan 61 tanesi miks tip polinöropati, 4 ü duyusal ve 4 ü de motor nöropati tanısı almıştır. Yapılan istatistik analizlerinde NSS ve NDS skorlama sistemlerinin bu sonuçlarla çok yakın korelasyon gösterdiği bulunmuştur (p

🔖

Cite This Article

ÖGE, A., DEMİR, S., AK, F., GEMALMAZ, A. (2022). Nörolojik semptom skorlama sistemlerinin diyabetik polinöropati tanısındaki önemi. Endokrinolojide Yönelişler, Cilt: 13 - Sayı: 2, 64–67. https://ajindex.com/articles/500855

References (14)

  1. Brown M J, Asbury AK. Diabetic neuropathy. Ann Neurol 15: 2-12, 1984
  2. Riddle MC. Diabetic neuropathies in the elderly: Management Update. Geriatrics 45: 32-36, 1990
  3. Dyck FJ. Dratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population based cohort: The Rochester Diabetic Neuropathy Study. Neurology 43: 817-824, 1993- 4. Yao ST, Hobbs JT, Irvine WT: Anlde systolic pressure measurements in arterial disease affecting the lower extremities. Brit J Surg 56: 676-679, 1969
  4. Young MJ, Uoulton Aj, Macleod Al:, Williams DRR, Sanksen I'll. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom Hospital Clinic Population. Diabetologia 36: 150-154, 1993
  5. O' Brien SP. Schwcdier M, Kertein MD. Nonoperative management of lower extremity arterial disease. Part I. Surgical Clinics of North America 78:393-408, 1998
  6. Thomas PK and Scaclding JW. Treatment of pain in diabetic neuro¬pathy. In: Dyck Pj, Thomas PK, Asbury AK, Winegrad Al and Porte D jr. (Eds.). Diabetic neuropathy, Philadelphia: Saunders WR, 1991: 216- 222 8. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton I J. The Rochester Diabetic Neuropathy Study: Design, criteria for types of neuropathy, selection bias and reproducibility of neuropathic tests. Neurology 41:799-807, 1991
  7. Dvck PJ, Kaernes JL. Daube J, O' Brien P and Service FJ. Clinical and neuropathologica! criteria for the siagnosis and Staging of diabetic polyneuropathy. Brain 108: 861-880,1985
  8. The DCCT Research Group. Factors in the development of niabetic Neuropathy. Diabetes 37:476-481, 1988
  9. Franklin GM, Kahn LB, bacter J, Marshall JA, Hamman RF. Sensory neuropathy in non-insulin dependent diabetes mellitus. The San Luis Valley Study. Amer J Epidemiol 131:633-643, 1990
  10. Dyck PJ. Detection, characterization and staging of polyneuropathy assessed in diabetics. Muscle Nerve 11:21-32, 1988
  11. Masson EA, Gem J, Hunt L, Boulton AJM. A novel approach to the diagnosis and assessment of symtomatic diabetic neuropathy. Pain 38:25-28, 1989
  12. Dyck PJ, Thomas PK, Lambert EH, Bunge R (Eds): Peripheral neuro¬pathy, Philadelphia: Saunders WD, 1984; 919-966
  13. Daube JR. Electrophysiologic testing in diabetic neuropathy, in Dyck PJ, Thomas PK, Asbury A, Winegrad A, Porte D (Eds): Diabetic Neuropathy, Philadelphia: Saunders WD,1987; 234-38
  14. Mulder DW, Lambert EH, Bastron VA, Sprague RG. The neuropathies